Lake Zurich, Ill.-based Fresenius Kabi will temporarily distribute normal saline imported from its Norway manufacturing facility to help ease the national saline shortage, according to a U.S. Food and Drug Administration news release.
The FDA has inspected the facility to ensure it meets FDA standards and is asking healthcare professionals to directly contact Fresenius Kabi to obtain the saline.
"While FDA cannot require a manufacturer to produce a product, the agency will continue to use all the tools at its disposal to mitigate this and other drug shortages," the news release said.
More Articles on Drug Shortages:
Nitroglycerin in Short Supply
AHA Seeks FDA Action on Saline, IV Solution Shortage
8 Statistics on Care Affected by Drug Shortages